Nick Leschly Bluebird Bio, Inc. (BLUE) insider trading activity

Nick Leschly is of bluebird bio, Inc.. Currently has a direct ownership of 0 shares of BLUE, which is worth approximately $0. The most recent transaction as insider was on Jun 02, 2025, when has been sold 1,245 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

100.0% 12M change

Total Value Held $0

Nick Leschly Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 02 2025	SELL Sale (or disposition) back to the issuer	-	1,245 Reduced 100.0%	0 Common Stock
May 30 2025	SELL Disposition due to a tender of shares in a change of control transaction	-	14,416 Reduced 92.05%	1,245 Common Stock
Nov 06 2024	BUY Grant, award, or other acquisition	-	24,900 Added 7.31%	315,839 Common Stock
Jun 16 2023	BUY Grant, award, or other acquisition	-	10,790 Added 3.58%	290,939 Common Stock
Jan 11 2023	SELL Open market or private sale	$33,462 $7.8 p/Share	4,290 Reduced 1.51%	280,149 Common Stock
Jun 22 2022	BUY Grant, award, or other acquisition	-	3,109 Added 1.08%	284,439 Common Stock
Jan 11 2022	SELL Open market or private sale	$48,856 $9.64 p/Share	5,068 Reduced 1.77%	281,330 Common Stock
Jan 10 2022	SELL Open market or private sale	$22,269 $9.4 p/Share	2,369 Reduced 0.82%	286,398 Common Stock
Nov 11 2021	BUY Other acquisition or disposition	-	43,688 Added 13.14%	288,767 Common Stock
Aug 02 2021	BUY Grant, award, or other acquisition	-	102,607 Added 20.04%	409,299 Common Stock
May 03 2021	SELL Open market or private sale	$13,387 $30.15 p/Share	444 Reduced 0.14%	306,692 Common Stock
Apr 05 2021	SELL Open market or private sale	$13,413 $30.21 p/Share	444 Reduced 0.14%	307,136 Common Stock
Mar 04 2021	BUY Exercise of conversion of derivative security	$1,118,452 $5.5 p/Share	203,355 Added 39.8%	307,580 Common Stock
Mar 02 2021	SELL Open market or private sale	$13,134 $29.58 p/Share	444 Reduced 0.42%	104,225 Common Stock
Feb 16 2021	BUY Grant, award, or other acquisition	-	18,000 Added 14.67%	104,669 Common Stock
Feb 02 2021	SELL Open market or private sale	$27,282 $45.93 p/Share	594 Reduced 0.68%	86,669 Common Stock
Jan 06 2021	SELL Open market or private sale	$455,385 $45.11 p/Share	10,095 Reduced 10.37%	87,263 Common Stock
Jan 05 2021	SELL Open market or private sale	$14,968 $44.95 p/Share	333 Reduced 0.34%	97,358 Common Stock
Dec 02 2020	SELL Open market or private sale	$20,575 $46.34 p/Share	444 Reduced 0.45%	97,691 Common Stock
Nov 02 2020	SELL Open market or private sale	$23,794 $53.59 p/Share	444 Reduced 0.45%	98,135 Common Stock
Oct 02 2020	SELL Open market or private sale	$23,747 $52.77 p/Share	450 Reduced 0.45%	98,579 Common Stock

Also insider at

SYBX

SYNLOGIC, INC. Healthcare

TSVT

2seventy bio, Inc. Healthcare

Nick Leschly

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BLUE shares.

Notify only if

Value

Insider Trading

Get notified when an Bluebird Bio, Inc. insider buys or sells BLUE shares.

Notify only if

Operation

Value

Type

News

Receive news related to bluebird bio, Inc.

Track Activities on BLUE

Account